[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100459047":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":52,"collaborators":55,"id":62,"slug":26,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":26,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Turku University Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"FMT enema","ACTIVE_COMPARATOR","FMT enema 3-5 days after standard antibiotic treatment",[13],"Other: FMT",{"label":15,"type":16,"description":17,"interventionNames":18},"plasebo enema","PLACEBO_COMPARATOR","placebo",[19],"Other: placebo enema",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"OTHER","FMT","Fecal microbiota transfer from a healthy and tested volunteer",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"placebo enema","colored water enema",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Teppo U Stenholm","CONTACT","023130000","teppo.stenholm@tyks.fi",[38],{"facility":39,"status":40,"city":41,"state":26,"zip":26,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Turku University hospital","RECRUITING","Turku","Finland",{"type":44,"coordinates":45},"Point",[46,47],22.26869,60.45148,{"lat":47,"lon":46},[50],{"name":51,"role":34,"phone":35,"phoneExt":26,"email":36},"Teppo Stenholm",{"type":53,"investigatorFullName":51,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Specialist in gastroenterology and internal medicine",[56,58,60],{"name":57,"class":22},"Satakunta Central Hospital",{"name":59,"class":22},"Helsinki University Central Hospital",{"name":61,"class":22},"PaijatHame Central Hospital","100459047",false,"NCT05257538","FMT in Initial CDI","Fecal Microbiota Transplantation in Initial Clostridioides Difficile Enteritis: a Randomized, Placebo-controlled Trial","FinCDI","Inclusion Criteria:\n\n* \\>18 years\n* C. difficile PCR in feces positive and clinical symptoms of enteritis.\n* Full resolution of diarrhea during antibiotic treatment for C. difficile\n* No other ongoing antibacterial treatments.\n* No ongoing probiotics.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Pregnant\n* Ongoing need for antibacterial treatment\n* Life expectancy \\\u003C 1 year\n* Prior C. difficile infection in preceding 3 months\n* Unable to provide written consent, due to dementia for example.\n* Fecal incontinence i.e. inability to retain enema.","ALL","18 Years","120 Years",{"count":73,"type":74},140,"ESTIMATED","INTERVENTIONAL",[77],"NA","The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.",[80],"Clostridioides Difficile Infection","2025-04-08",{"date":83,"type":84},"2025-04-11","ACTUAL",{"date":86,"type":84},"2021-08-01",{"date":88,"type":74},"2028-02-28",{"name":5,"class":6},1]